Impact of SARS-CoV-2 infection on risk of prematurity, birthweight and obstetric complications: A multivariate analysis from a nationwide, population-based retrospective cohort study.

ABSTRACT:

Objective

To determine the impact of maternal coronavirus disease 2019 (COVID-19) on prematurity, birthweight and obstetric complications.

Design

Nationwide, population-based retrospective cohort study.

Setting

National Programme de Médicalisation des Systèmes d'Information database in France.

Population

All single births from March to December 2020: 510 387 deliveries, including 2927 (0.6%) with confirmed COVID-19 in the mother and/or the newborn.

Methods

The group with COVID-19 was compared with the group without COVID-19 using the chi-square test or Fisher's exact test, and the Student's t test or Mann-Whitney U test. Logistic regressions were used to study the effect of COVID-19 on the risk of prematurity or macrosomia (birthweight ≥4500 g).

Main

SUBMITTER: Simon E 

PROVIDER: S-EPMC9111136 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature